Indian Immunologicals Limited collaboratively develops game-changing needle-free COVID-19 Intranasal Vaccine

Hyderabad, Aug 27 (Maxim News): Indian Immunologicals Limited has announced a live-attenuated needle-free intranasal booster vaccine developed against SARS-CoV-2 using codon deoptimization technology in collaboration with Griffith University, Australia.

Click Here To Join Us On WhatsApp

This groundbreaking work on the COVID-19 vaccine was published in the world’s leading science Journal ‘Nature Communications‘ on 26th August 2024.

A press release said that the danger due to COVID-19 is still not over and it is still killing around 1,700 people a week around the world. Among the different formats of vaccines available, it is well known that live attenuated vaccines generate a robust and broad-spectrum neutralizing antibody response.

Click Here To Join Us On WhatsApp

IIL’s needle-free intranasal booster vaccine against SARS-CoV-2 developed using codon deoptimization technology demonstrated remarkable stability and maintained safety in extensive animal studies, the press release said.  (Maxim News)


More Stories :

Now you can get the latest stories from Indtoday on Telegram every day. Click the link to subscribe.  Click to follow Indtoday’s Facebook pageTwitter and Instagram. For all the latest Hyderabad News update

Leave A Reply

Your email address will not be published.